Nutritional Trial BL01

A Randomized Double Blinded Controlled Trial of an Oral Nutritional Supplement Containing AN 777 in Older Hospitalized Patients

Nutritional Trial BL01

Description: A Randomized Double Blinded Controlled Trial of an Oral Nutritional Supplement Containing AN 777 in Older Hospitalized Patients

Drug: Supplement AN 777, Drug: Placebo

 

 

Primary Investigator: Keyes

Drug/Device Information
Oral nutritional supplement containing AN 777 in older patients hospitalized with heart failure, MI, pneumonia or COPD
Randomized to ready to drink control flavored beverage vs. ready to drink flavored beverage with AN 777
Beta-hydroxy-beta-methylbutyrate (HMB AN777) is an active metabolite of leucine that regulates muscle protein metabolism
Abbott Nutrition Abbott Laboratories
Major Inclusion and Exclusion
Age ≥ 65 admitted for primary diagnosis of heart failure, MI, pneumonia or COPD
Consent within 48 hours of hospital admission with expected stay of ≥ 3 days and ≤ 12 days
Must be ambulatory and can not be a nursing home resident
No DM
GFR can not be < 30
BMI can not be ≥ 40kg/m²